ShareValue.ai

ShareValue scores for AVNS: Valuation 57, Quality 68, Growth 48, Health 37.

AVNS
NYSE

Avanos Medical Inc

$24.92(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
57
Fair Value
Price vs Value
Quality
68
Moderate
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
37
Stressed
Financial Stability
Momentum
99
Bullish
Price Trend

Company Details

About

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Address: 5405 Windward Parkway, Alpharetta, GA, United States, 30004

Score Analysis

AI Investment Thesis

Data as of:Jul 9, 2026
|
Last calculated:Jul 9, 2026